The effect of transcranial brain stimulation on patients with schizophrenia
- Conditions
- The effect of TDCS of on schizophrenia.
- Registration Number
- IRCT20210406050874N1
- Lead Sponsor
- Tabriz University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 40
Having a diagnosis of psychiatric illness in Razi Hospital, Tabriz
No disability
Family consent to participate in the program
Having a diagnosis of Schizophrenia (diagnosis of schizophrenia is based on the DSM5 diagnostic criteria and SCID-based psychiatric interview and clinical examination)
Age under 18 and over 45 years
History of severe sensory-motor disorders
Vision problems
Hearing problems
Severe intelligence and cognitive impairments
Epilepsy and seizures
History of brain mass
Substance dependence
History of intracranial implants (such as prostheses, shunts, stimulators, electrodes)
The presence of any metal object that is close to the head (for example, inside the mouth) and can not be separated
Having a cardiac pacemaker
History of recent strokes and MI
History of degenerative brain disorders such as Alzheimer's and Parkinson's diseases.
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Serum levels of total and Phosphorylated Tau Protein in Patients with Schizophrenia. Timepoint: 2cc of fasting blood sample for each patient is taken once before starting and once after all sessions of TDCS. Method of measurement: By ELISA kits and in the laboratory.
- Secondary Outcome Measures
Name Time Method